Living through a heart attack makes you a survivor. But being a survivor means more than living through your event. It means taking care of yourself and doing all you can to help reduce your risk of another heart attack.
By joining Survivor Support, you’ll get:
We’re here to help you stay on track with your treatment plan and, most importantly, stay motivated. Because being a survivor means living your second chance.
By completing this registration, you are confirming that you are at least 18 years old, are a resident of the US, and would like to receive information in the future about BRILINTA® (ticagrelor) and related health information, including support related to your condition and treatment information.
AstraZeneca respects your personal health information. The information you provide may be used to send you health-related materials and to develop products, services, and programs. Third parties working on behalf of AstraZeneca may receive information that includes the date that you filled the prescription, the quantity of medication dispensed by your pharmacist, and your savings under the program. AstraZeneca, or third parties working on our behalf, will not sell or rent personal health information. If in the future you no longer want to receive these materials, please call 1-844-798-3617. Please visit www.azprivacynotice.com to review our Privacy Notice.
*Required.
THANK YOU
Thank you for signing up for Survivor Support.
BRILINTA is used to lower your chance of having, or dying from, a heart attack or stroke, but BRILINTA (and similar drugs) can cause bleeding that can be serious and sometimes lead to death. Instances of serious bleeding, such as internal bleeding, may require blood transfusions or surgery. While you take BRILINTA, you may bruise and bleed more easily and be more likely to have nosebleeds. Bleeding will also take longer than usual to stop.
Call your doctor right away if you have any signs or symptoms of bleeding while taking BRILINTA, including: severe, uncontrollable bleeding; pink, red, or brown urine; vomit that is bloody or looks like coffee grounds; red or black stool; or if you cough up blood or blood clots.
Do not stop taking BRILINTA without talking to the doctor who prescribes it for you. People who are treated with a stent, and stop taking BRILINTA too soon, have a higher risk of getting a blood clot in the stent, having a heart attack, or dying. If you stop BRILINTA because of bleeding, or for other reasons, your risk of a heart attack or stroke may increase. Tell all your doctors and dentists that you are taking BRILINTA. To decrease your risk of bleeding, your doctor may instruct you to stop taking BRILINTA 5 days before you have surgery. Your doctor should tell you when to start taking BRILINTA again, as soon as possible after surgery.
Take BRILINTA and aspirin exactly as instructed by your doctor. In most cases, you should not take a dose of aspirin higher than 100 mg daily because it can affect how well BRILINTA works. Tell your doctor if you take other medicines that contain aspirin. Do not take new medicines that contain aspirin.
Do not take BRILINTA if you have a history of bleeding in the brain, are bleeding now, or are allergic to ticagrelor or any of the ingredients in BRILINTA.
Slow heart rhythm has been reported with BRILINTA.
BRILINTA can cause serious side effects, including bleeding and shortness of breath. Call your doctor if you have new or unexpected shortness of breath or any side effect that bothers you or that does not go away. Your doctor can decide what treatment is needed.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. BRILINTA may affect the way other medicines work, and other medicines may affect how BRILINTA works. Tell your doctor if you are breastfeeding or plan to breastfeed. You should not breastfeed while being treated with BRILINTA.
Please read Medication Guide and Prescribing Information, including Boxed WARNINGS, for BRILINTA.
You may report side effects related to AstraZeneca products by clicking here.
